Canada markets close in 5 hours 37 minutes

Syndax Pharmaceuticals, Inc. (SNDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
20.52-0.22 (-1.06%)
As of 10:22AM EDT. Market open.
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-209,360
-209,360
-149,338
24,926
-73,158
Depreciation & amortization
12
12
33
43
89
Stock based compensation
30,951
30,951
16,019
13,317
9,057
Change in working capital
31,860
31,860
1,656
-9,597
-7,934
Accounts Payable
5,611
5,611
-1,319
2,161
-2,670
Other working capital
-160,601
-160,601
-133,675
29,002
-71,260
Other non-cash items
739
739
1,524
187
816
Net cash provided by operating activites
-160,601
-160,601
-133,675
29,131
-71,260
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-129
-
Purchases of investments
-354,606
-354,606
-495,346
-294,719
-278,937
Sales/Maturities of investments
472,215
472,215
308,933
253,975
136,407
Net cash used for investing activites
117,609
117,609
-186,188
-40,873
-142,530
Cash flows from financing activities
Debt repayment
0
0
-20,996
0
0
Common stock issued
258,094
258,094
181,390
86,337
278,060
Other financing activites
-
-
-
576
1
Net cash used privided by (used for) financing activities
264,132
264,132
172,254
118,464
304,424
Net change in cash
221,140
221,140
-147,609
106,722
90,634
Cash at beginning of period
74,471
74,471
222,080
115,358
24,724
Cash at end of period
295,611
295,611
74,471
222,080
115,358
Free Cash Flow
Operating Cash Flow
-160,601
-160,601
-133,675
29,131
-71,260
Capital Expenditure
-
-
-
-129
-
Free Cash Flow
-160,601
-160,601
-133,675
29,002
-71,260